Page last updated: 2024-09-02

s 14297 and gr 103691

s 14297 has been researched along with gr 103691 in 1 studies

Compound Research Comparison

Studies
(s 14297)
Trials
(s 14297)
Recent Studies (post-2010)
(s 14297)
Studies
(gr 103691)
Trials
(gr 103691)
Recent Studies (post-2010) (gr 103691)
150028017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V; Bervoets, K; Brocco, M; Dekeyne, A; Desposte, I; Gluck, L; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Rivet, JM1

Other Studies

1 other study(ies) available for s 14297 and gr 103691

ArticleYear
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: 2-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Biphenyl Compounds; Body Temperature; Catalepsy; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Furans; Humans; Indans; Naphthalenes; Oxazines; Piperazines; Prolactin; Pyrrolidines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3

1998